S. Okamoto

H. Nakasone, Y. Ishihara, K. Kawamura, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Preclinical study of a DNA vaccine targeting SARS-CoV-2

R. Morishita, H. Rakugi, Y. Matsuura, 2020, bioRxiv.

HLA-restricted presentation of WT1 tumor antigen in B-lymphoblastoid cell lines established using a maxi-EBV system

T. Kanda, T. Tsurumi, H. Fujiwara, 2012, Cancer Gene Therapy.

Adoptive transfer of genetically engineered WT1-specific cytotoxic T lymphocytes does not induce renal injury

S. Kitazawa, H. Ikeda, H. Shiku, 2014, Journal of Hematology & Oncology.

Safety and persistence of WT1-specific T-cell receptor gene-transduced lymphocytes in patients with AML and MDS.

T. Kidokoro, T. Naoe, H. Ikeda, 2017, Blood.

Rapid αβ TCR-mediated responses in γδ T cells transduced with cancer-specific TCR genes

N. Minato, Y. Tanaka, H. Shiku, 2009, Gene Therapy.

Tumor Growth Suppression of Pancreatic Cancer Orthotopic Xenograft Model by CEA-Targeting CAR-T Cells

Yizheng Wang, T. Tsuchikawa, Toru Nakamura, 2023, Cancers.

Modified DNA vaccine confers improved humoral immune response and effective virus protection against SARS-CoV-2 delta variant

R. Morishita, Masahiro Yamamoto, H. Rakugi, 2022, Scientific Reports.

A Functionally Superior Second-Generation Vector Expressing an Aurora Kinase-A-Specific T-Cell Receptor for Anti-Leukaemia Adoptive Immunotherapy

H. Shiku, H. Fujiwara, K. Kuzushima, 2016, PloS one.

Highly efficient genome editing for single-base substitutions using optimized ssODNs with Cas9-RNPs

T. Enoki, J. Mineno, S. Okamoto, 2019, Scientific Reports.

Improved expression and reactivity of transduced tumor-specific TCRs in human lymphocytes by specific silencing of endogenous TCR.

H. Ikeda, I. Kato, H. Shiku, 2009, Cancer research.

Novel adoptive T-cell immunotherapy using a WT1-specific TCR vector encoding silencers for endogenous TCRs shows marked antileukemia reactivity and safety.

H. Shiku, H. Fujiwara, K. Kuzushima, 2011, Blood.

A Promising Vector for TCR Gene Therapy: Differential Effect of siRNA, 2A Peptide, and Disulfide Bond on the Introduced TCR Expression

H. Ikeda, H. Shiku, H. Fujiwara, 2012, Molecular therapy. Nucleic acids.

Co-Introduced Functional CCR2 Potentiates In Vivo Anti-Lung Cancer Functionality Mediated by T Cells Double Gene-Modified to Express WT1-Specific T-Cell Receptor

H. Inoue, H. Shiku, H. Fujiwara, 2013, PloS one.

Adoptive transfer of genetically modified Wilms' tumor 1-specific T cells in a novel malignant skull base meningioma model.

H. Ikeda, T. Wakabayashi, H. Shiku, 2013, Neuro-oncology.

CAR-Modified Vγ9Vδ2 T Cells Propagated Using a Novel Bisphosphonate Prodrug for Allogeneic Adoptive Immunotherapy

Yizheng Wang, H. Shiku, H. Fujiwara, 2023, International journal of molecular sciences.

Intradermal administration of DNA vaccine targeting Omicron SARS-CoV-2 via pyro-drive jet injector provides the prolonged neutralizing antibody production via germinal center reaction

R. Morishita, H. Rakugi, M. Shimamura, 2023, Scientific reports.

Exhaustion, rather than lack of infiltration and persistence, of CAR-T cells hampers the efficacy of CAR-T therapy in an orthotopic PDAC xenograft model.

T. Tsuchikawa, Y. Hirokawa, Takuma Kato, 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Development of a chimeric cytokine receptor that captures IL-6 and enhances the antitumor response of CAR-T cells

S. Okamoto, Yasunori Amaishi, Hitomi Kasuya, 2024, Cell reports. Medicine.

T cell receptor gene‐modified allogeneic T cells with siRNA for endogenous T cell receptor induce efficient tumor regression without graft‐versus‐host disease

H. Ikeda, H. Shiku, J. Mineno, 2023, Cancer science.

Preclinical study of a DNA vaccine targeting SARS-CoV-2

R. Morishita, M. Shimamura, H. Nakagami, 2022, Current Research in Translational Medicine.